“…Inhibition of Hz formation by CQ and other quinoline antimalarials has been demonstrated under a variety of conditions. ,,− As described above, a number of interactions of these drugs with precrystalline forms of heme that can conceivably bring about such inhibition have been characterized by various spectroscopic methods, particularly in the case of CQ. − ,,,,− ,− Several tube-based and plate-based high-throughput assays have been developed to quantify the ability of a particular compound to inhibit Hz formation in vitro ,− (Table ). Typically, solutions with varying concentrations of the drug are incubated with a fixed concentration of FPIX under conditions that produce maximal Hz yield measured in the absence of drug, with the aim of determining the drug concentration at which 50% of Hz formed under control conditions is inhibited (Hz inhibitory IC 50 or β-hematin inhibitory activity (BHIA) IC 50 ).…”